Clerio Vision
Sasha Latypova has been working in the field since 2006 when they co-founded and became Executive Vice President of iCardiac Technologies, Inc. This venture-backed company focused on cardiac safety services for clinical trials and was a next generation ECG core laboratory that delivered superior services to pharmaceutical sponsors. In 2014, Latypova co-founded Clerio Vision, Inc. and took on the role of Executive Vice President and Director.
Sasha Latypova completed their MBA in Business Administration from The Tuck School of Business at Dartmouth between 1997 and 1999.
This person is not in any offices
Clerio Vision
Clerio Vision is developing a revolutionary product platform for the global ophthalmic market, based on technology licensed from the University of Rochester.